4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline has been researched along with Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appleby, VJ; Collingridge, GL; Corrêa, SA; Fitzjohn, SM; Garner, CC; Molnár, E; Nash, JE; Wu, H | 1 |
1 other study(ies) available for 4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline and Carcinoma
| Article | Year |
|---|---|
Disruption of the interaction between myosin VI and SAP97 is associated with a reduction in the number of AMPARs at hippocampal synapses.
Topics: Adaptor Proteins, Signal Transducing; Aminoquinolines; Animals; Animals, Newborn; Carcinoma; Cells, Cultured; Discs Large Homolog 1 Protein; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Green Fluorescent Proteins; Hippocampus; Humans; Membrane Proteins; Myosin Heavy Chains; Neurons; Patch-Clamp Techniques; Potassium Chloride; Protein Structure, Tertiary; Protein Subunits; Protein Transport; Rats; Receptors, AMPA; Synapses; Transfection | 2010 |